Daan Gene disclosed its earnings forecast, expecting an attributable net loss of 96 million to 135 million yuan for the first half of 2026, compared with a loss of 182 million yuan in the same period last year. The net loss after deducting non-recurring items is projected at 40 million to 56 million yuan, versus a loss of 265 million yuan a year earlier. Basic loss per share is estimated at 0.07 to 0.10 yuan. The company said the change in performance was mainly due to a reduction in credit impairment losses, an increase in investment income from associates, and lower operating costs, but a decline in the fair value of other non-current financial assets partially offset the improvement.
Da An Gene Co Ltd of Sun Yat-Sen UniversityCompany forecasts a net loss for first half of 2026, though narrower than prior year.